-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZAMEND NEURO INC: PLANS TO INITIATE PHASE II CLINICAL STUDY OF AL001 FOR TREATMENT OF PATIENTS WITH MDD IN Q4 OF 2025

Reuters·03/18/2025 12:09:37

Please log in to view news